Pierre Laurin | Chief Executive Officer
ProMetic Life Sciences Inc.

Pierre Laurin, Chief Executive Officer, ProMetic Life Sciences Inc.

Appearances:



Day 2 Orphan 15th Nov @ 08:35

Executive industry discussion: Intentions of pharmaceutical companies developing treatments for rare disease patients – What do they hope to achieve?

Plenary
 
  • The evolving role of pharma and multi-stakeholders
  • What are the challenges?
  • What are the options moving forward?
  • How do we work together to improve this?
Pierre Laurin, Chief Executive Officer, ProMetic Life Sciences Inc.
Scott L Pescatore, Oncology General Manager. Rare Diseases, Novartis

back to speakers